| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.063 | 0.2 |